Featured

Pretreatment with Dienogest in women with Endometriosis undergoing IVF after a previous failed cycle
Endometriosis is a benign chronic inflammatory estrogen-dependent disease and a well-known cause of infertility. Endometriosis may have a direct harmful effect on fertility not only due to the presence of adhesions and anatomic distortions, but also because of the intrinsic negative impact on oocyte development, embryogenesis, or implantat...
Role of Dienogest in Endometriosis in Young Women
Take Home Message: Endometriosis is estimated to affect 10–15% of women of childbearing age and as much as 15–30% of those with primary or secondary infertility. Endometriosis associated pelvic pain (EAPP) is the most common complaint of patients with endometriosis. It occurs when endometrial cells proliferate outside the uterus, for...
Dienogest vs continuous oral levonorgestrel/ Ethinyl Estradiol in patients with endometriosis: what's the best choice?
Combined oral contraceptives (COC) and progestogens are widely used for the treatment of endometriosis. TAKE HOME MESSAGE This study was carried out to compare the effect of dienogest (2mg) vs a combined oral contraceptive (levonorgestrel 0.1mg/ethinyl estradiol 0.02mg) on ovarian endometriomas, deep infiltrating endometriosis (DIE),...
Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis
Endometriosis is defined as the presence of endometrium-like tissue outside the uterus. It causes a chronic inflammatory reaction that may result in the formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body. It is a chronic disease associated with severe, life-impacting pain during periods, sexual...
Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries
The Journal of Obstetrics & Gynecology Research: An ovarian endometrioma is a cystic mass arising from ectopic endometrial tissue within the ovary. It contains thick, brown, tar-like fluid, which may be referred to as a "chocolate cyst." Endometriomas are often densely adherent to surrounding structures, such as the peritoneum, fallopian...
Dienogest in the Treatment of Endometriosis
Global Journal of Reproductive Medicine: Endometriosis is a common disease in up to 10% of women of reproductive age. It often causes symptoms such as dysmenorrhea, chronic pelvic pain, dyspareunia and dyschezia. It is also associated with ovarian endometrioma which requires surgery for both diagnosis and treatment. However, recurrence r...
A Clinician's Guide to the Treatment of Endometriosis with Elagolix
Journal of the Women’s Health: Published on April 2021 Endometriosis is an estrogen-dependent, inflammatory condition marked anatomically by the presence of extrauterine lesions containing endometrial glands and stroma. Affecting an estimated 6%–10% of women, endometriosis is one of the most common gynecologic conditions among reproduct...
Dienogest and the Risk of Endometriosis Recurrence Following Surgery
Journal of Minimally Invasive Gynecology: Published on December 2020 Endometriosis is a common condition affecting women of reproductive age, often presenting with pelvic pain and infertility. In addition to significantly impacting a woman’s quality of life, the treatment of endometriosis carries a considerable economic burden. TAKE...
Endometriosis Diagnosis and Treatment
The New England Journal of Medicine (NEJM): Endometriosis is defined as the presence of endometrium-like tissue outside the uterus. Figure 1. Endometriosis across the Life Course. Endometriosis is primarily diagnosed through surgical visualization — ideally, laparoscopy. Treatment consists of surgical removal of lesions and hormon...